Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001753926-21-000570
Filing Date
2021-10-14
Accepted
2021-10-14 16:30:50
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B4 g082389_424b4.htm 424B4 2274062
2 GRAPHIC g082389_img1.jpg GRAPHIC 21498
3 GRAPHIC g082389_img2.jpg GRAPHIC 52191
4 GRAPHIC g082389_img3.jpg GRAPHIC 97049
5 GRAPHIC g082389_img5.jpg GRAPHIC 9013
6 GRAPHIC g082389_img6.jpg GRAPHIC 19455
7 GRAPHIC g082389_img4.jpg GRAPHIC 29155
  Complete submission text file 0001753926-21-000570.txt   2590097
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-258741 | Film No.: 211323627
SIC: 2834 Pharmaceutical Preparations